Zyprexa ® (olanzapine)

Zyprexa® (olanzapine): Feeding tube

Administration of Zyprexa coated tablets or Zyprexa Velotab through a feeding tube is not part of the approved methods of administration. Lilly has no data to support the administration of Zyprexa through a gastric tube.

UK_cFAQ_OLZ045_Y1_FEEDING_TUBE
cFAQ
cFAQ
UK_cFAQ_OLZ045_Y1_FEEDING_TUBE
en-GB

Handling and Safety Concerns

Exposure to tablet powder (either airborne or by dermal contact) generated during the breaking or crushing of olanzapine tablets has the potential risks for contact dermatitis following repeated exposure.1

Symptoms have included rash with redness, swelling, and scaling of the affected skin areas. Positive reactions have been verified by patch testing with olanzapine (0.1%). Based on the clinical dose, olanzapine is highly potent.1

Likewise, olanzapine may be irritating to the eyes based on animal studies. Attention and care should be exercised not to inadvertently transfer material from the hands to the eye.2

Additional safety information about olanzapine can be found in the full prescribing information and the Material and Safety Data Sheet, available upon request from Eli Lilly and Company.

References

1Olanzapine [material safety data sheet]. Indianapolis, IN: Eli Lilly and Company; 2019.

2Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: January 08, 2021


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request